HIV patients successfully switch from shots to daily pill in new study
NCT ID NCT06104306
First seen Feb 16, 2026 · Last updated May 11, 2026 · Updated 12 times
Summary
This study looked at 33 adults with well-controlled HIV who switched from a monthly injectable treatment (CAB+RPV) to a daily oral pill (B/F/TAF). The main goal was to check safety over 12 weeks. Results showed the oral pill was safe and well-tolerated, offering a convenient alternative for those who cannot or prefer not to continue injections.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV-1-INFECTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
APHM - Hospital Sainte Marguerite
Marseille, France
-
BIOS Clinical Research
Palm Springs, California, 92262, United States
-
Bliss Health
Orlando, Florida, 32806, United States
-
Boston Medical Center
Boston, Massachusetts, 02118, United States
-
CHR Orleans
Orléans, 45100, France
-
CHU Bordeaux - Hopital Saint-Andre
Bordeaux, 33075, France
-
Centre Hospitalier Annecy Genevois
Pringy, 74374, France
-
Franco Felizarta, MD
Bakersfield, California, 93301, United States
-
HU de Strasbourg - Nouvel Hopital Civil
Strasbourg, France
-
Hamilton Health Sciences-SIS Clinic
Hamilton, L8L2X2, Canada
-
Indiana University Infectious Diseases Research
Indianapolis, Indiana, 46202, United States
-
Las Vegas Research Center
Las Vegas, Nevada, 89106, United States
-
Midway Immunology and Research Center
Ft. Pierce, Florida, 34982, United States
-
MultiCare Rockwood Main Clinic
Spokane, Washington, 99202, United States
-
Saint Michael's Medical Center
Newark, New Jersey, 07102, United States
-
St. Michael's Hospital
Toronto, M5B 1W8, Canada
-
UC San Diego AntiViral Research Center (AVRC)
San Diego, California, 92103, United States
-
University Health Network - Toronto General Hospital
Toronto, M5G 2C4, Canada
Conditions
Explore the condition pages connected to this study.